nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—ADRB2—chronic obstructive pulmonary disease	0.229	1	CbGaD
Pindolol—Nadolol—Salbutamol—chronic obstructive pulmonary disease	0.0676	0.187	CrCrCtD
Pindolol—Carteolol—Salbutamol—chronic obstructive pulmonary disease	0.0676	0.187	CrCrCtD
Pindolol—Levobunolol—Salbutamol—chronic obstructive pulmonary disease	0.0676	0.187	CrCrCtD
Pindolol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0604	0.18	CbGbCtD
Pindolol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0594	0.178	CbGbCtD
Pindolol—Bupranolol—Salbutamol—chronic obstructive pulmonary disease	0.0488	0.135	CrCrCtD
Pindolol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0457	0.137	CbGbCtD
Pindolol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0457	0.137	CbGbCtD
Pindolol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0451	0.135	CbGbCtD
Pindolol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0451	0.135	CbGbCtD
Pindolol—Isoprenaline—Formoterol—chronic obstructive pulmonary disease	0.0397	0.11	CrCrCtD
Pindolol—Isoprenaline—Arformoterol—chronic obstructive pulmonary disease	0.0397	0.11	CrCrCtD
Pindolol—Isoprenaline—Salbutamol—chronic obstructive pulmonary disease	0.0301	0.0833	CrCrCtD
Pindolol—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0115	0.0343	CbGbCtD
Pindolol—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0115	0.0343	CbGbCtD
Pindolol—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0102	0.0306	CbGbCtD
Pindolol—Levobunolol—ADRB2—chronic obstructive pulmonary disease	0.000273	0.089	CrCbGaD
Pindolol—Metipranolol—ADRB2—chronic obstructive pulmonary disease	0.00026	0.0849	CrCbGaD
Pindolol—Carteolol—ADRB2—chronic obstructive pulmonary disease	0.000232	0.0757	CrCbGaD
Pindolol—Nadolol—ADRB2—chronic obstructive pulmonary disease	0.000207	0.0675	CrCbGaD
Pindolol—Esmolol—ADRB2—chronic obstructive pulmonary disease	0.000207	0.0675	CrCbGaD
Pindolol—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00333	CcSEcCtD
Pindolol—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000199	0.0033	CcSEcCtD
Pindolol—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.0033	CcSEcCtD
Pindolol—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000198	0.00329	CcSEcCtD
Pindolol—Bupranolol—ADRB2—chronic obstructive pulmonary disease	0.000197	0.0644	CrCbGaD
Pindolol—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000197	0.00326	CcSEcCtD
Pindolol—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000195	0.00323	CcSEcCtD
Pindolol—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000195	0.00323	CcSEcCtD
Pindolol—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000195	0.00323	CcSEcCtD
Pindolol—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00322	CcSEcCtD
Pindolol—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000194	0.00322	CcSEcCtD
Pindolol—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000194	0.00321	CcSEcCtD
Pindolol—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00321	CcSEcCtD
Pindolol—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000194	0.00321	CcSEcCtD
Pindolol—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.00321	CcSEcCtD
Pindolol—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000193	0.00319	CcSEcCtD
Pindolol—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000191	0.00317	CcSEcCtD
Pindolol—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000191	0.00316	CcSEcCtD
Pindolol—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.00316	CcSEcCtD
Pindolol—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00019	0.00315	CcSEcCtD
Pindolol—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00314	CcSEcCtD
Pindolol—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00314	CcSEcCtD
Pindolol—Tension—Formoterol—chronic obstructive pulmonary disease	0.000189	0.00313	CcSEcCtD
Pindolol—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.00313	CcSEcCtD
Pindolol—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00312	CcSEcCtD
Pindolol—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.0031	CcSEcCtD
Pindolol—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000187	0.0031	CcSEcCtD
Pindolol—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.00309	CcSEcCtD
Pindolol—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00306	CcSEcCtD
Pindolol—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00306	CcSEcCtD
Pindolol—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000184	0.00304	CcSEcCtD
Pindolol—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00303	CcSEcCtD
Pindolol—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00303	CcSEcCtD
Pindolol—Betaxolol—ADRB2—chronic obstructive pulmonary disease	0.000182	0.0594	CrCbGaD
Pindolol—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000182	0.00301	CcSEcCtD
Pindolol—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000181	0.003	CcSEcCtD
Pindolol—Atenolol—ADRB2—chronic obstructive pulmonary disease	0.00018	0.0589	CrCbGaD
Pindolol—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.00299	CcSEcCtD
Pindolol—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00018	0.00299	CcSEcCtD
Pindolol—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00297	CcSEcCtD
Pindolol—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00295	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000177	0.00294	CcSEcCtD
Pindolol—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00293	CcSEcCtD
Pindolol—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00292	CcSEcCtD
Pindolol—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.00292	CcSEcCtD
Pindolol—Bisoprolol—ADRB2—chronic obstructive pulmonary disease	0.000176	0.0574	CrCbGaD
Pindolol—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000175	0.00289	CcSEcCtD
Pindolol—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00289	CcSEcCtD
Pindolol—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000171	0.00284	CcSEcCtD
Pindolol—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00282	CcSEcCtD
Pindolol—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00017	0.00282	CcSEcCtD
Pindolol—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.00282	CcSEcCtD
Pindolol—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000169	0.0028	CcSEcCtD
Pindolol—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000168	0.00278	CcSEcCtD
Pindolol—Acebutolol—ADRB2—chronic obstructive pulmonary disease	0.000166	0.0543	CrCbGaD
Pindolol—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00276	CcSEcCtD
Pindolol—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000166	0.00276	CcSEcCtD
Pindolol—Oxprenolol—ADRB2—chronic obstructive pulmonary disease	0.000165	0.0539	CrCbGaD
Pindolol—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00271	CcSEcCtD
Pindolol—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00271	CcSEcCtD
Pindolol—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00271	CcSEcCtD
Pindolol—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00271	CcSEcCtD
Pindolol—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00271	CcSEcCtD
Pindolol—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00271	CcSEcCtD
Pindolol—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.0027	CcSEcCtD
Pindolol—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000163	0.0027	CcSEcCtD
Pindolol—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.0027	CcSEcCtD
Pindolol—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.0027	CcSEcCtD
Pindolol—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.0027	CcSEcCtD
Pindolol—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00266	CcSEcCtD
Pindolol—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00266	CcSEcCtD
Pindolol—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00266	CcSEcCtD
Pindolol—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00016	0.00265	CcSEcCtD
Pindolol—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.00265	CcSEcCtD
Pindolol—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00265	CcSEcCtD
Pindolol—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00265	CcSEcCtD
Pindolol—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000159	0.00264	CcSEcCtD
Pindolol—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000157	0.0026	CcSEcCtD
Pindolol—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.0026	CcSEcCtD
Pindolol—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00256	CcSEcCtD
Pindolol—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00256	CcSEcCtD
Pindolol—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00256	CcSEcCtD
Pindolol—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00255	CcSEcCtD
Pindolol—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00255	CcSEcCtD
Pindolol—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00255	CcSEcCtD
Pindolol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.00255	CcSEcCtD
Pindolol—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00255	CcSEcCtD
Pindolol—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00254	CcSEcCtD
Pindolol—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00254	CcSEcCtD
Pindolol—Alprenolol—ADRB2—chronic obstructive pulmonary disease	0.000151	0.0493	CrCbGaD
Pindolol—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00251	CcSEcCtD
Pindolol—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000151	0.0025	CcSEcCtD
Pindolol—Betaxolol—CYP1A2—chronic obstructive pulmonary disease	0.000151	0.0491	CrCbGaD
Pindolol—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00246	CcSEcCtD
Pindolol—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00243	CcSEcCtD
Pindolol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00243	CcSEcCtD
Pindolol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000146	0.00242	CcSEcCtD
Pindolol—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00242	CcSEcCtD
Pindolol—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00241	CcSEcCtD
Pindolol—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.0024	CcSEcCtD
Pindolol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00237	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00237	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00237	CcSEcCtD
Pindolol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00235	CcSEcCtD
Pindolol—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00235	CcSEcCtD
Pindolol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000141	0.00234	CcSEcCtD
Pindolol—Metoprolol—ADRB2—chronic obstructive pulmonary disease	0.000141	0.0459	CrCbGaD
Pindolol—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00232	CcSEcCtD
Pindolol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00014	0.00232	CcSEcCtD
Pindolol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.00232	CcSEcCtD
Pindolol—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.00231	CcSEcCtD
Pindolol—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00014	0.00231	CcSEcCtD
Pindolol—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000139	0.0023	CcSEcCtD
Pindolol—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000139	0.0023	CcSEcCtD
Pindolol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.0023	CcSEcCtD
Pindolol—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.00229	CcSEcCtD
Pindolol—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000138	0.00229	CcSEcCtD
Pindolol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000138	0.00229	CcSEcCtD
Pindolol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000138	0.00228	CcSEcCtD
Pindolol—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000137	0.00227	CcSEcCtD
Pindolol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000136	0.00226	CcSEcCtD
Pindolol—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00225	CcSEcCtD
Pindolol—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00225	CcSEcCtD
Pindolol—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00225	CcSEcCtD
Pindolol—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000135	0.00224	CcSEcCtD
Pindolol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00224	CcSEcCtD
Pindolol—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00224	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00224	CcSEcCtD
Pindolol—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00222	CcSEcCtD
Pindolol—Pain—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00222	CcSEcCtD
Pindolol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00222	CcSEcCtD
Pindolol—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00222	CcSEcCtD
Pindolol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00222	CcSEcCtD
Pindolol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00221	CcSEcCtD
Pindolol—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000133	0.0022	CcSEcCtD
Pindolol—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000133	0.0022	CcSEcCtD
Pindolol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00219	CcSEcCtD
Pindolol—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00218	CcSEcCtD
Pindolol—Pain—Montelukast—chronic obstructive pulmonary disease	0.000131	0.00218	CcSEcCtD
Pindolol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000131	0.00217	CcSEcCtD
Pindolol—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.00216	CcSEcCtD
Pindolol—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00013	0.00216	CcSEcCtD
Pindolol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00013	0.00215	CcSEcCtD
Pindolol—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00215	CcSEcCtD
Pindolol—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00214	CcSEcCtD
Pindolol—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00214	CcSEcCtD
Pindolol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000129	0.00214	CcSEcCtD
Pindolol—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00213	CcSEcCtD
Pindolol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000129	0.00213	CcSEcCtD
Pindolol—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00213	CcSEcCtD
Pindolol—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00213	CcSEcCtD
Pindolol—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00213	CcSEcCtD
Pindolol—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00212	CcSEcCtD
Pindolol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00212	CcSEcCtD
Pindolol—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.0021	CcSEcCtD
Pindolol—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.0021	CcSEcCtD
Pindolol—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00208	CcSEcCtD
Pindolol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00206	CcSEcCtD
Pindolol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00206	CcSEcCtD
Pindolol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000124	0.00205	CcSEcCtD
Pindolol—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000123	0.00203	CcSEcCtD
Pindolol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.00203	CcSEcCtD
Pindolol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000122	0.00203	CcSEcCtD
Pindolol—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00202	CcSEcCtD
Pindolol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.00202	CcSEcCtD
Pindolol—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.00202	CcSEcCtD
Pindolol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00201	CcSEcCtD
Pindolol—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00201	CcSEcCtD
Pindolol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00194	CcSEcCtD
Pindolol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000116	0.00191	CcSEcCtD
Pindolol—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.00191	CcSEcCtD
Pindolol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.00187	CcSEcCtD
Pindolol—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000113	0.00187	CcSEcCtD
Pindolol—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000111	0.00184	CcSEcCtD
Pindolol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.00184	CcSEcCtD
Pindolol—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00011	0.00183	CcSEcCtD
Pindolol—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000109	0.0018	CcSEcCtD
Pindolol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.00178	CcSEcCtD
Pindolol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000107	0.00178	CcSEcCtD
Pindolol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00176	CcSEcCtD
Pindolol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000105	0.00174	CcSEcCtD
Pindolol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.00174	CcSEcCtD
Pindolol—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000104	0.00172	CcSEcCtD
Pindolol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.00172	CcSEcCtD
Pindolol—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000102	0.00169	CcSEcCtD
Pindolol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.00168	CcSEcCtD
Pindolol—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.0001	0.00166	CcSEcCtD
Pindolol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	9.98e-05	0.00165	CcSEcCtD
Pindolol—Vomiting—Formoterol—chronic obstructive pulmonary disease	9.98e-05	0.00165	CcSEcCtD
Pindolol—Isoprenaline—ADRB2—chronic obstructive pulmonary disease	9.97e-05	0.0325	CrCbGaD
Pindolol—Rash—Formoterol—chronic obstructive pulmonary disease	9.89e-05	0.00164	CcSEcCtD
Pindolol—Rash—Arformoterol—chronic obstructive pulmonary disease	9.89e-05	0.00164	CcSEcCtD
Pindolol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	9.89e-05	0.00164	CcSEcCtD
Pindolol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	9.89e-05	0.00164	CcSEcCtD
Pindolol—Weight increased—Prednisone—chronic obstructive pulmonary disease	9.88e-05	0.00164	CcSEcCtD
Pindolol—Headache—Arformoterol—chronic obstructive pulmonary disease	9.83e-05	0.00163	CcSEcCtD
Pindolol—Headache—Formoterol—chronic obstructive pulmonary disease	9.83e-05	0.00163	CcSEcCtD
Pindolol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	9.8e-05	0.00162	CcSEcCtD
Pindolol—Vomiting—Montelukast—chronic obstructive pulmonary disease	9.77e-05	0.00162	CcSEcCtD
Pindolol—Rash—Montelukast—chronic obstructive pulmonary disease	9.69e-05	0.00161	CcSEcCtD
Pindolol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	9.68e-05	0.00161	CcSEcCtD
Pindolol—Depression—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.0016	CcSEcCtD
Pindolol—Headache—Montelukast—chronic obstructive pulmonary disease	9.63e-05	0.0016	CcSEcCtD
Pindolol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.42e-05	0.00156	CcSEcCtD
Pindolol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.36e-05	0.00155	CcSEcCtD
Pindolol—Rash—Salbutamol—chronic obstructive pulmonary disease	9.34e-05	0.00155	CcSEcCtD
Pindolol—Syncope—Prednisolone—chronic obstructive pulmonary disease	9.34e-05	0.00155	CcSEcCtD
Pindolol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.33e-05	0.00155	CcSEcCtD
Pindolol—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.32e-05	0.00155	CcSEcCtD
Pindolol—Nausea—Formoterol—chronic obstructive pulmonary disease	9.32e-05	0.00155	CcSEcCtD
Pindolol—Headache—Salbutamol—chronic obstructive pulmonary disease	9.28e-05	0.00154	CcSEcCtD
Pindolol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	9.15e-05	0.00152	CcSEcCtD
Pindolol—Nausea—Montelukast—chronic obstructive pulmonary disease	9.13e-05	0.00151	CcSEcCtD
Pindolol—Bradycardia—Prednisone—chronic obstructive pulmonary disease	8.85e-05	0.00147	CcSEcCtD
Pindolol—Nausea—Salbutamol—chronic obstructive pulmonary disease	8.8e-05	0.00146	CcSEcCtD
Pindolol—Hallucination—Prednisone—chronic obstructive pulmonary disease	8.65e-05	0.00143	CcSEcCtD
Pindolol—Isoprenaline—CYP1A1—chronic obstructive pulmonary disease	8.55e-05	0.0279	CrCbGaD
Pindolol—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.5e-05	0.00141	CcSEcCtD
Pindolol—Shock—Prednisolone—chronic obstructive pulmonary disease	8.36e-05	0.00139	CcSEcCtD
Pindolol—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.29e-05	0.00138	CcSEcCtD
Pindolol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.22e-05	0.00136	CcSEcCtD
Pindolol—Angiopathy—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.00131	CcSEcCtD
Pindolol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	7.69e-05	0.00127	CcSEcCtD
Pindolol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.63e-05	0.00127	CcSEcCtD
Pindolol—Mental disorder—Prednisone—chronic obstructive pulmonary disease	7.62e-05	0.00126	CcSEcCtD
Pindolol—Pain—Prednisolone—chronic obstructive pulmonary disease	7.27e-05	0.0012	CcSEcCtD
Pindolol—Propranolol—ADRB2—chronic obstructive pulmonary disease	7.09e-05	0.0232	CrCbGaD
Pindolol—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7e-05	0.00116	CcSEcCtD
Pindolol—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.8e-05	0.00113	CcSEcCtD
Pindolol—Syncope—Prednisone—chronic obstructive pulmonary disease	6.79e-05	0.00113	CcSEcCtD
Pindolol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.65e-05	0.0011	CcSEcCtD
Pindolol—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.44e-05	0.00107	CcSEcCtD
Pindolol—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.44e-05	0.00107	CcSEcCtD
Pindolol—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.00106	CcSEcCtD
Pindolol—Oedema—Prednisone—chronic obstructive pulmonary disease	6.18e-05	0.00102	CcSEcCtD
Pindolol—Propranolol—CYP1A1—chronic obstructive pulmonary disease	6.08e-05	0.0199	CrCbGaD
Pindolol—Shock—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.00101	CcSEcCtD
Pindolol—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.06e-05	0.001	CcSEcCtD
Pindolol—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.03e-05	0.000999	CcSEcCtD
Pindolol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.97e-05	0.00099	CcSEcCtD
Pindolol—Propranolol—CYP1A2—chronic obstructive pulmonary disease	5.87e-05	0.0191	CrCbGaD
Pindolol—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.63e-05	0.000933	CcSEcCtD
Pindolol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.62e-05	0.000932	CcSEcCtD
Pindolol—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000926	CcSEcCtD
Pindolol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.55e-05	0.000919	CcSEcCtD
Pindolol—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.44e-05	0.000901	CcSEcCtD
Pindolol—Rash—Prednisolone—chronic obstructive pulmonary disease	5.36e-05	0.000888	CcSEcCtD
Pindolol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.35e-05	0.000888	CcSEcCtD
Pindolol—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.32e-05	0.000883	CcSEcCtD
Pindolol—Headache—Prednisolone—chronic obstructive pulmonary disease	5.32e-05	0.000883	CcSEcCtD
Pindolol—Constipation—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.000876	CcSEcCtD
Pindolol—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000844	CcSEcCtD
Pindolol—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.05e-05	0.000837	CcSEcCtD
Pindolol—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.05e-05	0.000837	CcSEcCtD
Pindolol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.88e-05	0.000809	CcSEcCtD
Pindolol—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000735	CcSEcCtD
Pindolol—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.37e-05	0.000724	CcSEcCtD
Pindolol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.23e-05	0.000701	CcSEcCtD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	4.16e-05	0.00343	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	4.16e-05	0.00343	CbGpPWpGaD
Pindolol—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.14e-05	0.00342	CbGpPWpGaD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.11e-05	0.00339	CbGpPWpGaD
Pindolol—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.08e-05	0.000677	CcSEcCtD
Pindolol—HTR1A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	4.02e-05	0.00332	CbGpPWpGaD
Pindolol—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	4e-05	0.0033	CbGpPWpGaD
Pindolol—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.93e-05	0.000651	CcSEcCtD
Pindolol—ADRB3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.91e-05	0.00323	CbGpPWpGaD
Pindolol—Rash—Prednisone—chronic obstructive pulmonary disease	3.89e-05	0.000646	CcSEcCtD
Pindolol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.89e-05	0.000645	CcSEcCtD
Pindolol—Headache—Prednisone—chronic obstructive pulmonary disease	3.87e-05	0.000641	CcSEcCtD
Pindolol—Nausea—Prednisone—chronic obstructive pulmonary disease	3.67e-05	0.000608	CcSEcCtD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.59e-05	0.00296	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	3.56e-05	0.00294	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.55e-05	0.00293	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.5e-05	0.00289	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	3.43e-05	0.00283	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	3.41e-05	0.00281	CbGpPWpGaD
Pindolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.4e-05	0.00281	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	3.31e-05	0.00273	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	3.24e-05	0.00267	CbGpPWpGaD
Pindolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	3.18e-05	0.00263	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	3.17e-05	0.00261	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.15e-05	0.0026	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.13e-05	0.00258	CbGpPWpGaD
Pindolol—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.13e-05	0.00258	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.06e-05	0.00252	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	3.05e-05	0.00251	CbGpPWpGaD
Pindolol—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.99e-05	0.00247	CbGpPWpGaD
Pindolol—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.96e-05	0.00244	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.92e-05	0.0024	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.86e-05	0.00236	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.77e-05	0.00228	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.74e-05	0.00226	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.73e-05	0.00225	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.71e-05	0.00224	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.68e-05	0.00221	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.65e-05	0.00219	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.65e-05	0.00218	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.61e-05	0.00215	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.61e-05	0.00215	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.59e-05	0.00214	CbGpPWpGaD
Pindolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.49e-05	0.00205	CbGpPWpGaD
Pindolol—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.49e-05	0.00205	CbGpPWpGaD
Pindolol—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.45e-05	0.00202	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.44e-05	0.00201	CbGpPWpGaD
Pindolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.44e-05	0.00201	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.38e-05	0.00197	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.38e-05	0.00196	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.35e-05	0.00194	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.33e-05	0.00192	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.33e-05	0.00192	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.32e-05	0.00192	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.27e-05	0.00187	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.22e-05	0.00183	CbGpPWpGaD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.22e-05	0.00183	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.2e-05	0.00181	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.13e-05	0.00176	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.13e-05	0.00176	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.11e-05	0.00174	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.11e-05	0.00174	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.1e-05	0.00173	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.09e-05	0.00172	CbGpPWpGaD
Pindolol—HTR1B—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.08e-05	0.00172	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.08e-05	0.00171	CbGpPWpGaD
Pindolol—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.07e-05	0.00171	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.06e-05	0.0017	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.06e-05	0.0017	CbGpPWpGaD
Pindolol—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.05e-05	0.00169	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.04e-05	0.00168	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.04e-05	0.00168	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.02e-05	0.00166	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.99e-05	0.00164	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.98e-05	0.00163	CbGpPWpGaD
Pindolol—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.91e-05	0.00157	CbGpPWpGaD
Pindolol—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.88e-05	0.00155	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.87e-05	0.00154	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.86e-05	0.00153	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.83e-05	0.00151	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.82e-05	0.0015	CbGpPWpGaD
Pindolol—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.81e-05	0.00149	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.8e-05	0.00148	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.79e-05	0.00148	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	1.79e-05	0.00147	CbGpPWpGaD
Pindolol—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.78e-05	0.00147	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.78e-05	0.00146	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.77e-05	0.00146	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.7e-05	0.0014	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.69e-05	0.0014	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.69e-05	0.00139	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.66e-05	0.00137	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.65e-05	0.00136	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.64e-05	0.00136	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.63e-05	0.00134	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.62e-05	0.00134	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.61e-05	0.00133	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.61e-05	0.00132	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.59e-05	0.00131	CbGpPWpGaD
Pindolol—HTR1A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	1.59e-05	0.00131	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.57e-05	0.0013	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.56e-05	0.00129	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.55e-05	0.00128	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.55e-05	0.00128	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.53e-05	0.00126	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.47e-05	0.00122	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.45e-05	0.0012	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.4e-05	0.00116	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.34e-05	0.0011	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.32e-05	0.00109	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.32e-05	0.00109	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.29e-05	0.00106	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.26e-05	0.00104	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.26e-05	0.00104	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.26e-05	0.00104	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.25e-05	0.00103	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.24e-05	0.00102	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.24e-05	0.00102	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.22e-05	0.001	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.2e-05	0.000987	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.19e-05	0.000983	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.17e-05	0.000968	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.15e-05	0.000951	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.15e-05	0.000948	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.12e-05	0.000926	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.07e-05	0.000879	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.06e-05	0.000875	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.05e-05	0.000865	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.05e-05	0.000863	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.03e-05	0.000847	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.02e-05	0.000841	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1e-05	0.000828	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1e-05	0.000828	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1e-05	0.000828	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.82e-06	0.00081	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.82e-06	0.00081	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.63e-06	0.000794	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.6e-06	0.000792	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.6e-06	0.000792	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.55e-06	0.000788	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.53e-06	0.000786	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.48e-06	0.000782	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	9.37e-06	0.000773	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.32e-06	0.000769	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.22e-06	0.00076	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.18e-06	0.000757	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.11e-06	0.000752	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.98e-06	0.000741	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.78e-06	0.000724	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.71e-06	0.000718	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.68e-06	0.000716	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.62e-06	0.000711	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.57e-06	0.000707	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.33e-06	0.000687	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.3e-06	0.000684	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.15e-06	0.000672	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.97e-06	0.000658	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.91e-06	0.000652	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.71e-06	0.000636	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.34e-06	0.000605	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.18e-06	0.000592	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.12e-06	0.000587	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.07e-06	0.000583	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.02e-06	0.000579	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.82e-06	0.000563	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.68e-06	0.000551	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.53e-06	0.000538	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.47e-06	0.000533	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.42e-06	0.00053	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.34e-06	0.000523	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.3e-06	0.000519	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.18e-06	0.00051	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.05e-06	0.000499	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.02e-06	0.000497	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.78e-06	0.000477	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.75e-06	0.000474	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.67e-06	0.000468	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.63e-06	0.000464	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.55e-06	0.000458	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.51e-06	0.000454	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.42e-06	0.000447	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.38e-06	0.000444	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.15e-06	0.000425	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.13e-06	0.000423	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.12e-06	0.000422	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.12e-06	0.000422	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	5.06e-06	0.000417	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.04e-06	0.000415	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5e-06	0.000413	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.93e-06	0.000406	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.92e-06	0.000406	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.89e-06	0.000404	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.87e-06	0.000402	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.82e-06	0.000397	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.73e-06	0.00039	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.71e-06	0.000388	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.64e-06	0.000382	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	4.62e-06	0.000381	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.58e-06	0.000378	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.51e-06	0.000372	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.48e-06	0.000369	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.38e-06	0.000361	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.31e-06	0.000355	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.25e-06	0.000351	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.16e-06	0.000343	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.82e-06	0.000315	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.82e-06	0.000315	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.76e-06	0.00031	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.75e-06	0.000309	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.68e-06	0.000304	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.63e-06	0.0003	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.6e-06	0.000297	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.59e-06	0.000296	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.55e-06	0.000293	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.51e-06	0.00029	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.5e-06	0.000289	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.45e-06	0.000285	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.44e-06	0.000283	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.43e-06	0.000283	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.35e-06	0.000277	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.28e-06	0.000271	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.26e-06	0.000269	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.15e-06	0.000259	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.1e-06	0.000256	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.09e-06	0.000255	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.04e-06	0.000251	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.98e-06	0.000245	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.91e-06	0.00024	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.89e-06	0.000239	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.88e-06	0.000237	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.85e-06	0.000235	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.83e-06	0.000233	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.79e-06	0.00023	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.77e-06	0.000228	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.75e-06	0.000227	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.69e-06	0.000222	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.63e-06	0.000217	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.47e-06	0.000204	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.42e-06	0.000199	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.36e-06	0.000195	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.34e-06	0.000193	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.27e-06	0.000187	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.22e-06	0.000183	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.22e-06	0.000183	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.17e-06	0.000179	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.17e-06	0.000179	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.15e-06	0.000177	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.13e-06	0.000175	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.1e-06	0.000173	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.01e-06	0.000166	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.87e-06	0.000154	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.83e-06	0.000151	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.79e-06	0.000147	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.71e-06	0.000141	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.67e-06	0.000138	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.63e-06	0.000135	CbGpPWpGaD
